Qiaoyang Ning - Concepedia

Author

Qiaoyang Ning

Also Known As

Q Y Ning, Qiao-yang Ning, Qiaoyang Ning, Qiwen Ning

Publications

387

Citations

H-Index

Concepts

All Affiliations

Qiaoyang Ning is an author at Chinese PLA General Hospital specializing in medicine, tumor biology, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	234
2	Cell Biology	2	2	196
3	Epidemiology	1	1	38
4	Hepatology	1	1	38
5	Immunology	1	1	100

Qiaoyang Ning

Publications

380

Citations

H-Index

Page 1

	Year	Citations
A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells Xiaoning Gao, Ji Lin, Qiaoyang Ning, PLoS ONE Mixed-phenotype Acute LeukemiaApoptosisImmunologyCell DeathCell Cycle	2013	100
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation Xuefeng Gao, Fei Yan, Jiang Lin, Leukemia Tumor BiologyCell RegulationMedicineDnmt3a TransactivationCell Biology	2015	96
Increased PRAME-Specific CTL Killing of Acute Myeloid Leukemia Cells by Either a Novel Histone Deacetylase Inhibitor Chidamide Alone or Combined Treatment with Decitabine Yushi Yao, Jihao Zhou, Lixin Wang, PLoS ONE	2013	77
High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin’s lymphoma in China Chaoyu Wang, Bing Xia, Qiaoyang Ning, Annals of Hematology Hepatitis DLymphoid NeoplasiaHepatologyViral HepatitisHepatitis B	2017	38
A novel epigenetic <i>AML1‐ETO/THAP10/miR‐383</i> mini‐circuitry contributes to t(8;21) leukaemogenesis Yonghui Li, Qiaoyang Ning, Jinlong Shi, EMBO Molecular Medicine	2017	37
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia Ailing Deng, Qiaoyang Ning, Lei Zhou, Scientific Reports	2016	32

Page 1